Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
基本信息
- 批准号:8432053
- 负责人:
- 金额:$ 35.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-06 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesB cell differentiationB-Cell DevelopmentB-LymphocytesBloodBlood CellsBone MarrowCell LineCell ProliferationCell modelCommitDataDefectDevelopmentDiseaseDoseDown-RegulationEventGene ExpressionGene Expression ProfilingGene TargetingGenerationsGenesGoalsHealthHematological DiseaseHematopoieticHematopoietic stem cellsHomeostasisHoxA proteinImmune systemImmunodeficiency and CancerImmunologic Deficiency SyndromesInfectionInterventionKnowledgeLearningLeukocytesLifeLigandsLinkLymphoidLymphopoiesisMediatingMicroarray AnalysisMolecularMolecular TargetMusPathway interactionsPatternPlayProcessProductionProteinsRag1 MouseReceptor Protein-Tyrosine KinasesRegulationRegulator GenesReporterResearch DesignRoleSeriesSignal TransductionStem Cell DevelopmentStem cellsTCF3 geneTestingTranscriptanimal databasecytokinedesignfightingfunctional genomicshelix-loop-helix protein differentiation inhibitorhumoral immunity deficiencyinsightinterestleukemianoveloverexpressionprogenitorprotein Bresearch studystem cell biologytranscription factor
项目摘要
DESCRIPTION (provided by applicant): B lymphocytes are critical blood cells and altered production or function can cause significant disease. We are interested in understanding how blood stem cells initiate B cell development. Delineating the normal B cell developmental pathway will provide insight into the molecular and cellular basis of many hematologic diseases. Although considerable progress has been made in understanding the generation of naive B cells from committed B cell precursors, little is known about how this process begins. This project will exploit exciting new findings concerning an unexpected regulatory connection between the receptor tyrosine kinase Flt3, HoxA proteins, and the B cell fate determinant EBF. Our new data suggest that this regulatory connection plays an important role in regulating the stem cell to Pro-B transition, and hence, the numbers of B lymphocytes generated. Specifically, we will learn how Flt3 signaling initiates a series of events, gradually biasing multipotential progenitors in bone marrow into the B lineage. Exciting new data revealed that Flt3 signaling, in a ligand-dose dependent fashion, regulates the activity of the primary B cell fate determinant, E2A, a key regulator of the EBF gene. Once expressed, EBF orchestrates B cell differentiation. Gene expression profiling of an EBF-/- cell line pointed to novel role for EBF during B cell development, namely controlling expression of a developmentally regulated cluster of HoxA proteins. Elucidating regulatory circuits that control HoxA expression is important, as dysregulated expression impairs B cell differentiation. First we will determine the molecular events between Flt3 signaling and EBF expression. Then we will determine the regulatory connection between EBF, HoxA, and Flt3 that controls the production of B lymphocytes. Overall, these experiments will provide basic knowledge of a vital process, the production of white blood cells that make antibodies to fight infections. The information should help identify molecular targets for intervention in blood cell cancers and immunodeficiency diseases.
描述(由申请人提供):B淋巴细胞是关键的血细胞,其产生或功能改变可导致严重疾病。我们有兴趣了解造血干细胞如何启动B细胞发育。阐明正常的B细胞发育途径将有助于深入了解许多血液病的分子和细胞基础。虽然在了解幼稚B细胞从定型B细胞前体的产生方面已经取得了相当大的进展,但对这一过程如何开始知之甚少。该项目将利用令人兴奋的新发现,关于受体酪氨酸激酶Flt 3,HoxA蛋白和B细胞命运决定因子EBF之间的意想不到的调节连接。我们的新数据表明,这种调节连接在调节干细胞向Pro-B转化中起着重要作用,因此,产生的B淋巴细胞的数量。具体来说,我们将了解Flt 3信号如何启动一系列事件,逐渐将骨髓中的多能祖细胞偏向B谱系。令人兴奋的新数据显示,Flt 3信号,在配体剂量依赖性的方式,调节活性的主要B细胞的命运决定因素,E2 A,EBF基因的关键调节。一旦表达,EBF协调B细胞分化。EBF-/-细胞系的基因表达谱分析指出EBF在B细胞发育过程中的新作用,即控制发育调节的HoxA蛋白簇的表达。阐明控制HoxA表达的调节回路是重要的,因为失调的表达损害B细胞分化。首先,我们将确定Flt 3信号转导和EBF表达之间的分子事件。然后,我们将确定EBF,HoxA和Flt 3之间的调节连接,控制B淋巴细胞的产生。总的来说,这些实验将提供一个重要过程的基本知识,即产生白色血细胞,使抗体对抗感染。这些信息应该有助于确定干预血细胞癌和免疫缺陷疾病的分子靶点。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hoxa9 regulates Flt3 in lymphohematopoietic progenitors.
- DOI:10.4049/jimmunol.0904203
- 发表时间:2010-12-01
- 期刊:
- 影响因子:0
- 作者:Gwin K;Frank E;Bossou A;Medina KL
- 通讯作者:Medina KL
Cell extrinsic alterations in splenic B cell maturation in Flt3-ligand knockout mice.
- DOI:10.1002/iid3.54
- 发表时间:2015-06
- 期刊:
- 影响因子:3.2
- 作者:Dolence, Joseph J;Gwin, Kimberly A;Shapiro, Mariya B;Hsu, Fan-Chi;Shapiro, Virginia S;Medina, Kay L
- 通讯作者:Medina, Kay L
Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
PIM-1失调对鼠骨髓B细胞发育的发育阶段特异性作用。
- DOI:10.1186/s12865-016-0152-1
- 发表时间:2016-06-10
- 期刊:
- 影响因子:3
- 作者:Xu Z;Gwin KA;Li Y;Medina KL
- 通讯作者:Medina KL
Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors.
来自 Flt3 多能祖细胞的 B、NK 和 DC 谱系细胞的发育和分化对 Hoxa9 的差异要求。
- DOI:10.1186/1471-2172-14-5
- 发表时间:2013
- 期刊:
- 影响因子:3
- 作者:Gwin,Kimberly;Dolence,JosephJ;Shapiro,MariyaB;Medina,KayL
- 通讯作者:Medina,KayL
Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1.
- DOI:10.1371/journal.pone.0078408
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Medina KL;Tangen SN;Seaburg LM;Thapa P;Gwin KA;Shapiro VS
- 通讯作者:Shapiro VS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kay Lynn Medina其他文献
Kay Lynn Medina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kay Lynn Medina', 18)}}的其他基金
Cell-extrinsic emergency myelopoiesis regulated by ABCB7
ABCB7 调控的细胞外紧急骨髓细胞生成
- 批准号:
10675321 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of the lymphoid cell fate by Hoxa9
Hoxa9 对淋巴细胞命运的调节
- 批准号:
10546476 - 财政年份:2022
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of the lymphoid cell fate by Hoxa9
Hoxa9 对淋巴细胞命运的调节
- 批准号:
10390559 - 财政年份:2022
- 资助金额:
$ 35.96万 - 项目类别:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
骨髓来源的同种异体反应性人浆细胞的维持和靶向
- 批准号:
9164092 - 财政年份:2016
- 资助金额:
$ 35.96万 - 项目类别:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
骨髓来源的同种异体反应性人浆细胞的维持和靶向
- 批准号:
9307716 - 财政年份:2016
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of erythroid maturation by the transcriptional repressor NKAP
转录抑制因子 NKAP 对红细胞成熟的调节
- 批准号:
8911512 - 财政年份:2015
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
7799155 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
8040992 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
8232043 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
7650758 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 35.96万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 35.96万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 35.96万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 35.96万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别: